Vancouver, British Columbia – October 10, 2025 – Pangea Natural Foods Inc. (CSE:PNGA) (OTC:PNGAF), also referred to as “Pangea” or “the Company,” is pleased to announce that its wholly owned subsidiary, Amino Innovations, is expanding its market presence through sponsorships and featured exhibitions at three prominent health and longevity events this October.
MoreLife Biohacking Summit, October 11-12, 2025 | Fort Lauderdale, Florida
Amino Innovations is a proud sponsor and exhibitor at the MoreLife Biohacking Summit, which stands as one of the fastest-growing conferences in the global longevity movement. This year’s summit will feature keynote speakers such as Gary Brecka, a renowned human biologist and founder of The Ultimate Human; Lara Trump, a wellness advocate and former Co-Chair of the Republican National Committee; and Tito Ortiz, a UFC Hall of Famer and early biohacker. The event serves as a gathering point for entrepreneurs, athletes, and wellness professionals focused on optimizing health and enhancing human performance.
The Healthspan Summit, October 3-5, 2025 | Los Angeles, California
Earlier this month, Amino Innovations sponsored and exhibited at the Healthspan Summit, a leading forum dedicated to cellular medicine and regenerative health innovation. The event showcased notable speakers including Dr. William Seeds, a pioneer in peptide and cellular repair science; David Perez, a leader in regenerative and functional medicine; and Dr. Stephanie Venn-Watson, a physician-scientist and longevity expert. Amino Innovations’ participation at the Healthspan Summit provided an opportunity to connect with prominent clinicians, wellness entrepreneurs, and investors focused on advancing peptide science and next-generation therapeutic delivery systems.
Both summits offered Amino Innovations a platform to actively display its non-injectable peptide products to an engaged audience comprising health professionals and performance enthusiasts. Live demonstrations and direct discussions allowed attendees to personally experience the convenience and efficacy of Amino’s delivery formats, sparking significant interest from clinic operators, athletes, and wellness influencers. The company’s presence across these two events positioned Amino as an emerging innovator and reinforced its mission to make “Peptides, Reimagined” a reality within the global market.
Disrupt Business 2025, October 17-19, 2025 | Orlando, California
Amino Innovations is also excited to announce that Justin Kirkland, Co-Founder and Chief Science Officer, will be a featured speaker at Disrupt Business 2025, a key conference for health practitioners and wellness entrepreneurs. His session will explore needle-free peptide delivery systems and bioavailable formulations, offering a preview of Amino Innovations’ upcoming peptide patch launch and its potential to redefine convenient, at-home peptide therapy.
About Pangea Natural Foods Inc.
Pangea Natural Foods Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.
On Behalf of the Board of Directors
“Pratap Sandhu”
Pratap Sandhu
Chief Executive Officer, Corporate Secretary and Director
+1 (604) 765-8069
Forward-Looking Information
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. The forward-looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that the acquisition or related matters will be completed as proposed or at all. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.